Overview: Zynerba Pharmaceuticals is a company developing cannabinoid therapies for rare and near-rare neuropsychiatric conditions. The company’s leading drug candidate is a pharmaceutical-grade transdermal CBD gel. This transdermal CBD gel, named ZYN002, is undergoing multiple clinical trials which are testing...

You must subscribe to Cannabis Investor’s Report Lifetime to view this content.

To learn more and access special member pricing contact our VIP team at 1-866-298-7257. 

Sign In

Enter your details below.